Source: The Market Herald

Acrux: Acrux (ASX:ACR) launches prilocaine and lidocaine cream in US

Acrux (ACR) and its partner, Padagis, launch a prilocaine and lidocaine cream...

Read full article »
Acrux's Competitors | Acrux's News | Acrux's Financials
Stay up-to-date with the latest news on Acrux
Annual Revenue
$100K-5.0M
Employees
25-100
Michael Kotsanis's photo - Managing Director & CEO of Acrux

Managing Director & CEO

Michael Kotsanis

CEO Approval Rating

84/100

Read more
Stay up-to-date with the latest news on Acrux